![]() ![]() “Canada will be the first market offering the i-FACTOR+ MATRIX product, which leverages the clinically proven P-15 osteogenic cell-binding peptide combined with a collagen carrier for optimized handling. Assessments up to 24 months included radiographs, CT scan, VAS, and ODI. A total of 40 patients underwent PLIF surgery, with each patient as control. “We are excited to announce that i-FACTOR+ Matrix is now fully available in Canada through our distributor Surgi-One and can be used in both spine and general orthopedic applications,” said Glen Kashuba, Chief Executive Officer of Cerapedics. Overview: I-Factor is a Biological Bone Graft from Cerapedics and is the only bone graft substitute that uses a unique peptide attachment factor (P-15(tm)). Lauweryns and Raskin (2015) examined the safety and efficacy of bone graft material ABM/P-15 (iFACTOR) for use in posterior lumbar interbody fusion (PLIF). “Canada will be the first market offering the i-FACTOR+ MATRIX product, which leverages the clinically proven P-15 osteogenic cell-binding peptide combined with a collagen carrier for optimized handling.” Favorite “We are excited to announce that i-FACTOR+ Matrix is now fully available in Canada through our distributor Surgi-One and can be used in both spine and general orthopedic applications,” said Glen Kashuba, Chief Executive Officer of Cerapedics. Both deliver fully prepared entrées that you can heat and. In the U.S., i-FACTOR received premarket approval in 2015 for use in single-level anterior cervical fusion. Subscription-based meal delivery services like Factor and Freshly can be an appealing option for those looking to save time on meal prep. i-FACTOR Peptide Enhanced Bone Graft was approved in the EU in 2008 and Australia in 2010 for orthopedic applications in the spine and extremities. i-FACTOR Peptide Enhanced Bone Graft Technology Platform i-FACTOR Bone Graft is an advanced biologic that is. I-FACTOR+ MATRIX uses small proprietary peptide technology supports bone growth through cell attraction, attachment and activation. The B2B marketplace for medical equipment. This follows Health Canada approval in September. Cerapedics commenced full commercial availability of i-FACTOR®+ MATRIX for surgical implantation in Canada. ![]()
0 Comments
Leave a Reply. |